The relationship between the structure and biological actions of green tea catechins

Food Chemistry

Volumn 141, Issue 3, 2013, Pages 3282-3289

  Braicu, Cornelia ^a,b   Ladomery, Michael R ^c   Chedea, Veronica S ^d,e   Irimie, Alexandru ^a,b   Berindan Neagoe, Ioana ^a,b  

^a THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^d Laboratory of Animal Biology   (Romania)

^e SHIMANE UNIVERSITY   (Japan)

Author keywords

Alternative splicing; Cancer; Catechins; Molecular targets; Pro antioxidant

Indexed keywords

BIOCHEMISTRY; PHENOLS; POLYPHENOLIC COMPOUNDS; VITAMINS;

ALTERNATIVE SPLICING; CANCER; CATECHINS; MOLECULAR TARGETS; PRO/ANTIOXIDANT;

FLAVONOIDS;

ADIPONECTIN; CATECHIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FREE RADICAL; GLUTATHIONE TRANSFERASE; HYDROXYL GROUP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 8; MESSENGER RNA; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SURVIVAL MOTOR NEURON PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ALTERNATIVE RNA SPLICING; ANTIANGIOGENIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTHRITIS; ATHEROSCLEROSIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DRUG BIOAVAILABILITY; DRUG MECHANISM; EXON; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIPID PEROXIDATION; MELANOMA CELL; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TEA; UTERINE CERVIX CANCER;

EID: 84879813767     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2013.05.122     Document Type: Review

References (86)

1. Agarwal, C., Sharma, Y., Zhao, J., & Agarwal, R. (2006). Inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clinical Cancer Re search, 2921-2932
2. Aggarwal, B., & Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology, 71, 1397-1421
3. Ahmad, N., Feyes, D., Nieminen, A.-L., Agarwal, R., & Mukhtar, H. (1997). Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Journal of the National Cancer Institute, 89 1881-1886 (Pubitemid 28009824)
4. Ahmed, S., Marotte, H., Kwan, K., Ruth, J. H., Campbell, P. L., Rabquer, B. J., et al. (2008). Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proceedings of the National Academy of Sciences of the United States of America, 105, 14692-14697
5. Ahn, W. S., Huh, S. W., Bae, S. M., Lee, I. P., Lee, J. M., Namkoong, S. E., et al. (2003). A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA and Cell Biology, 22(3), 217-224 (Pubitemid 36578095)
6. Anderson, S. L., Qiu, J., & Rubin, B. Y. (2003). EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochemical and Biophysical Research Communications, 310, 627-633 (Pubitemid 37163710)
7. Balentine, D. A., Wiseman, S. A., & Bouwens, L. C. (1997). The chemistry of tea flavonoids. Critical Reviews in Food Science and Nutrition, 37(8), 693-704 (Pubitemid 127349613)
8. Baliga, M., Meleth, S., & Katiyar, S. (2005). Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clinical Cancer Research, 11, 1918-1927 (Pubitemid 40471858)
9. Béliveau, R., & Gingras, D. (2007). Role of nutrition in preventing cancer. Canadian Family Physician, 53(11), 1905-1911 (Pubitemid 351198326)
10. Bode, A., & Dong, Z. (2009). Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail. Cancer Prevention Research (Philadelphia), 2(6), 514-517
11. Burz, C., Berindan-Neagoe, I., Balacescu, O., & Irimie, A. (2009). Apoptosis in cancer: Key molecula r signaling pathways and therapy targets. Acta Oncologica, 1, 9-11
12. Carlson, J. R., Bauer, B. A., Vincent, A., Limburg, P. J., & Wilson, T. (2007). Reading the tea leaves: Anticarcinogenic properties of (-)-epigallocatechin-3-gallate. Mayo Clinic Proceedings, 82(6), 725-732 (Pubitemid 46878096)
13. Cavet, M., Harrington, K., Vollmer, T., Ward, K., & Zhang, J.-Z. (2011). Antiinflammatory and anti-oxidative effects of the green tea poly phenol epigallocatechin gallate in human corneal epithelial cells. Molecular Vision, 17, 533-542
14. Chacko, S Thambi, P., Kuttan, R., & Nishigaki, I. (2010). Beneficial effects of green tea: A literature review. Chinese Medicine, 5, 13. http://dx.doi.org/10.1186/1749-8546-5-13
15. Chantre, P., & Lairon, D (2002). Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine, 9, 3-8 (Pubitemid 34184203)
16. Chedea, V. S., Braicu, C., & Socaciu, C. (2010). Antioxidant/ prooxidant activity of a polyphenolic grape seed extract. Food Chemistry, 121, 132-139
17. Chen, L., & Zhang, H. Y. (2007). Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules, 12, 946-957
18. Cho, S. Y., Park, P. J., Shin, H. J., Kim, Y.-K., Shin, D. W., Shin, E. S., et al. (2007). (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. American Journal of Physiology Endocrinology and Metabolism, 292, E1166-E1172. http://dx.doi.org/10.1152/ajpendo.00436.2006 (Pubitemid 46536517)
19. Clark, J., & You, M. (2006). Chemoprevention of lung cancer by tea. Molecular Nutrition & Food Research, 50, 144-151 (Pubitemid 43325655)
20. D?Archivio, M., Santangelo, C., Scazzocchio, B., Varì, R., Filesi, C., Masella, R., et al. (2008). Modulatory e ffects of polyphenols on apoptosis induction: Relevance for cancer prevention. International Journal of Molecular Sciences, 9(3), 213-228 (Pubitemid 351482110)
21. Dorai, T., & Aggarwal, B. (2004). Role of chemopreventive agents in cancer therapy. Cancer Letters, 215, 129-140 (Pubitemid 39370030)
22. Hong, J., Lu, H., Meng, X., Ryu, J. H., Hara, Y., & Yang, C. S. (2002). Stability, cellular uptake, biotransformation, and efflux of tea polyphenol epigallocatechin-3-gallate in Hat-29 colon adenocarcinoma cells. Cancer Research, 62, 7241-7246 (Pubitemid 36025245)
23. Inoue, M., Robien, K., Wang, R., Van Den Berg, D., Koh, W.-P., & Yu, M. (2008). Green tea intake, MTHFR/TYMS genotype and breast cancer risk: The Singapore Chinese health study. Carcinogenesis, 29(10), 1967-1972
24. Intra, J., & Kuo, S.-M. (2007). Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal Caco-2 cells. Chemico-Biological Interactions, 169(2), 91-99 (Pubitemid 47125871)
25. Junkun, J., Selman, S. H., Swiercz, R., & Skrzypczak-Jankun, E. (1997). Why drinking tea could prevent cancer. Nature, 387, 561 (Pubitemid 27248750)
26. Kanadzu, M., Yuquan, L., & Morimoto, K. (2006). Dual function of (-)-epigallocatechin gallate (EGCG) in healthy human lymphocytes. Cancer Letters, 241(2), 250-255 (Pubitemid 44163036)
27. Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research, 66, 2500-2505
28. Kim, E.-Y., Ham, S.-K., Brakes, D., Ma, Q., & Han, O. (2011). Ascorbic acid offsets the inhibitory effect of bioactive dietary polyphenolic compounds on transepithelial iron transport in Caco-2 intestinal cells. Journal of Nutrition, 25, 48-54. http://dx.doi.org/10.3945/jn.110.134031
29. Ko, C. H., Lau, K. M., Choy, W. Y., & Leung, P. C. (2009). Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate on bone metabolism. Journal of Agricultural and Food Chemistry, 57(16), 7293-7297
30. Kondo, T., Ohta, T., Igura, K., Hara, Y., & Kaji, K. (2002). Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, throgh inhibition of VEGF receptor binding. Cancer Letters, 180(2), 139-144 (Pubitemid 34327366)
31. Lamy, S., Gingras, D., & Béliveau, R. (2002). Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Research, 62, 381-389
32. Lim, Y. C., & Cha, Y. Y. (2011). Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. Journal of Surgical Oncology. http://dx.doi.org/10.1002/jso.21999
33. Liu, J., Xing, J., & Fei, Y. (2008). Green tea (Camellia sinensis) and cancer prevention: A systematic review of randomized trials and epidemiological studies. Chinese Medical Journal, 12-17. http://dx.doi.org/10. 1186/1749-8546-3-12
34. Lu, G., Liao, J., Yang, G., Reuhl, K. R., Hao, X., & Yang, C. S. (2006). Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Rese arch, 66, 11494-11501 (Pubitemid 46009983)
35. Lung, H. L., Wong, M., & Leung, K. N. (2002). Anti-proliferative and differentiationinducing activities of the green tea catechin epigallocatechin-3-gallate (EGCG) on the human eosinophili c leukemia EoL-1 cell line. Life Science, 72(3), 257-268 (Pubitemid 35335817)
36. Mandel, S., Amit, T., Kalfon, L., Reznichenko, L., & Youdim, M. (2008). Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. Journal of Nutrition, 138, 1578S-1583S.
37. Mandel, S., Maor, G., & Youdim, M. B. (2004). Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: Effect of neuroprotective drugs rapomorphine and green tea polyphenol (-)- epigallocatechin-3-gallate. Journal of Molecular Neuroscience, 24(3), 401-416 (Pubitemid 41389377)
38. Muzolf-Panek, M., Gliszczyń ska-Ś wiglo, A., de Haan, L., Aarts, J. M. M. J. G., Vervoort, J., Tyrakowska, B. et al. (2008). Prooxidant activity of catechins induces EpREmediated gene expression. Chemical Research in Toxicology, 21(12), 2352-2360
39. http://dx.doi.org/10.1021/tx8001498
40. Nagao, T., Hase, T., & Tokimitsu, I. (2007). A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity, 15, 1473-1483 (Pubitemid 47110911)
41. http://dx.doi.org/10.1038/oby.2007.176
42. Nagle, D., Ferreira, D., & Zhou, Y.-D. (2006). Epigallocatechin-3- gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry, 67(17), 1849-1855 (Pubitemid 44291411)
43. Nanjo, F., Mori, M., Goto, K., & Hara, Y. (1999). Radical scavenging activity of tea catechins and their related compounds. Bioscience, Biotechnology, and Biochemistry, 63(9), 1621-1623 (Pubitemid 129555156)
44. Nihal, M, Ahmad, N., Mukhtar, H., & Wood, G. S. (2005). Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma. International Journal of Cance r, 114, 513-521 (Pubitemid 40349609)
45. Ostrowska, J., & Skrzydlewska, E. (2006). The comparison of effect of catechins and green tea extract on oxidative modification of LDL in vitro. Advances in Medical Sciences, 51, 299-305
46. Pandey, K. B., & Rizvi, S. I. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity, 2(5), 270-278
47. Rains, T. M., Agarwal, S., & Maki, K. C. (2011). Antiobesity effects of green tea catechins: A mechanistic review. Nutritional Biochemistry, 22(1), 1-7
48. Rajamanickam, S., & Agarwal, R. (2008) . Natural products and colon cancer: Current status and future prospects. Drug Development Research, 69(7), 460-471
49. Ravindranath, M., Ramasamy, V., Moon, S., Ruiz, C., & Muthugounder, S. (2009). Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). Nature, 6(4), 523-530
50. Ren, W., Qiao, Z., Wang, H., Zhu, L., & Zhang, L. (2003). Flavonoids: Promising anticancer agents. Medicinal Research Reviews, 23(4), 519-534 (Pubitemid 36706514)
51. Rice-Evans, C. A., Miller, N. J., Bolwell, P. G., Bramley, P. M., & Pridham, J. B. (1995). The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radical Research, 22(4), 375-383
52. Rimbach, G., Melchin, M., Moehring, J., & Wagner, A. E. (2009). Polyphenols from cocoa and vascular health-a critical review. International Journal of Molecular Sciences, 10(10), 4290-4309
53. Rodenberg, J., & Brown, P. (2009). A novel look into estrogen receptor-negative breast cancer prevention with the natural, m ultifunctional signal transduction inhibitor deguelin. Cancer Prevention Research, 2, 915-918
54. Saeki, K., Hayakawa, S., Isemura, M., & Miyase, T. (2000). Importance of a pyrogalloltype structure in catechin compounds for apoptosis-inducing activity. Phytochemistry, 53(3), 391-394 (Pubitemid 30096922)
55. Sakla, M. S., & Lorson, C. L. (2008). Induction of full-length survival motor neuron by polyphenol botanical compounds. Human Genetic s, 122, 635-643
56. Sartippour, M., Pietras, R., Marquez-Garban, D., Chen, H.-W., Heber, D., Henning, S., et al. (2006). The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis, 27(12), 2424-2433 (Pubitemid 44884099)
57. Sazuka, M., Isemura, M., & Isemura, S. (1998). Interaction between the carboxylterminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate. Bioscience, Biotechnology, and Biochemistry, 62(5), 1031- 1032 (Pubitemid 128473739)
58. Seeram, N. P., Cichewicz, R. H., Chandra, A., & Nair, M. G. (2003). Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits. Journal of Agriculture and Food Chemistry, 51, 1948-1951
59. Shahidi, F. (2000). Antioxidants in food and food antioxidants. Nahrung, 44(3), 158-163
60. Shammas, M., Neri, P., Koley, H., Batchu, R., Bertheau, R., Munshi, V., et al.(2006). Specific killing of multiple myeloma cells by (-)- epigallocatechin-3-gallate extracted from green tea: Biologic activity and therapeutic implications. Blood, 108(8), 2804-2810
61. Shin, D. W., Kim, S. N., Lee, S. M., Lee, W., Song, M. J., Park, S. M., et al. (2009). (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivat ion. Biochemical Pharmacology, 77(1), 125-133 (Pubitemid 351948839)
62. Shin, D. W., Kim, S. N., Lee, S. M., Lee, W., Song, M. J., Park, S. M., et al. (2009). (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivat ion. Biochemical Pharmacology, 77(1), 125-133
63. Simons, C. C., Hughes, L. A., Arts, I. C., Goldbohm, R. A., van den Brandt, P. A., & Weijenberg, M. P. (2009). Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the Netherlands Cohort Study. International Journal of Cancer, 125(12), 2945-2952
64. Srebrow, A., & Kornblihtt, A. R. (2006). The connection between splicing and cancer. Journal of Cell Science, 119, 2635-2641 (Pubitemid 44184000)
65. Stammler, G., & Volm, M. (1997). Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer-Drugs, 8(3), 265-278
66. Sumanasekera, C., Watt, D. S., & Stamm, S. (2008). Substances that can change alternative splice-site selection. Biochemical Society Transactions, 36, 483-490 (Pubitemid 351839360)
67. S utherland, B., Rahman, R., & Appleto, I. (2006). Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. Journal of Nutritional Biochemistry, 17(5), 291-306
68. Suzuki, J., Ogawa, M., Sagesaka, Y., & Isobe, M. (2006). Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovascular Research, 69(1), 272-279. http://dx.doi.org/10.1016/j.cardiores.2005.07.009 (Pubitemid 41814828)
69. Tabassum, H., Parvez, S., Rehman, H., Banerjee, B. D., & Raisuddin, S. (2007). Catechin as an antioxidant in liver mitochondrial toxicity: Inhibition of tamoxifen-Induced protein oxidation and lipid peroxidation. Journal of Biochemical and Molecular Toxicology, 21(3), 110-117 (Pubitemid 47080837)
70. Tachibana, H. (2009). Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum of Nutrition, 61, 156-169
71. Tang, F. Y., Nguyen, N., & Meydani, M. (2003). Green tea catechins inhibit VEGFinduced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. International Journal of Cancer, 106(6), 871-878 (Pubitemid 37071665)
72. Tsuneki, H., Ishizuka, M., Terasawa, M., Wu, J. B., Sasaoka, T., & Kimura, I. (2004). Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacology, 4, 18-21
73. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology, 39, 44-84 (Pubitemid 44566469)
74. Velayutham, P., Babu, A., & Liu, D. (2008). Green tea catechins and cardiovascular health: An update. Current Medicinal Chemistry, 15(18), 1840-1850
75. Weinreb, O., Amit, T., Mandel, S., & Youdim, M. (2009). Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: A reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes & Nutrition, 4(4), 283-296
76. Weinreb, O., Mandel, S., & Youdim, M. (2003). CDNA gene expression profile homology of antioxidants and their antiap optotic and proapoptotic activities in human neuroblastoma cells. FASEB Journal, 3, 0017-0935
77. Wolfram, S., Wang, Y., & Thielecke, F. (2006). Anti-obesity effects of green tea: From bedside to bench. Molecular Nutrition & Food Research, 50(2), 176-187 (Pubitemid 43325659)
78. Xia, E.-Q., Deng, G.-F., Guo, Y.-J., & Li, & Li, H.-B. (2010). Biological activities of polyphenols from grapes. International Journal of Molecular Sciences 11(2), 622-646
79. Yamauchi, R., Sasaki, M., & Yoshida, K. (2009). Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Toxicology in Vitro, 23(5), 834-839
80. Yang, C., Ju, J., Lu, G., & Xiao, A. (2008). Cancer prevention by tea and tea polyphenols. Asia Pacific Journal of Clinical Nutrition, 17(1), 245-248
81. Yang, C. S., & Wang, H. (2011). Mechanistic issues concerning cancer prevention by tea catechins. Molecular Nutrition & Food Research, 55(6), 819-831. http://dx.doi.org/10.1002/mnfr.201100036
82. Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009). Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nature Reviews Cancer, 9, 429-439. http://dx.doi.org /10.1038/nrc2641
83. Youn, H., Lee, J., Saitoh, S., Miyake, K., Kang, K., Choi, Y., et al. (2006). Suppression of MyD88-and TRIF-dependent signalling pathways of toll-like receptor by (S)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochemical Pharmacology, 72, 850-859 (Pubitemid 44313886)
84. Zaveri, N. T. (2006). Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Scien ces, 78, 2073-2080
85. Zhang, M., Holman, C. D. A. J., Huang, J. P., & Xie, X. (2008). Green tea and the prevention of breast cancer: A case-control study in southeast China. Carcinogenesis, 29(8), 1594-1600. http://dx.doi.org/10.1093/carcin/bgn129
86. Zheng, L. T., Ryu, G. M., Kwon, B. M., Lee, W. H., & Suk, K. (2008). Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: Inhibition of microglial neurotoxicity. Eu ropean Journal of Pharmacology, 588(1), 106-113.